Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.000001 par value per share
-
Shares outstanding
-
6.57M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
71.9M
-
Shares change
-
+1.31M
-
Total reported value, excl. options
-
$1.28B
-
Value change
-
+$23.2M
-
Number of buys
-
26
-
Number of sells
-
-24
-
Price
-
$17.88
Significant Holders of Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) as of Q3 2021
71 filings reported holding TIL - Instil Bio, Inc. - Common Stock, $0.000001 par value per share as of Q3 2021.
Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.9M shares
.
Largest 10 shareholders include Vivo Capital, LLC (12.5M shares), FMR LLC (12.5M shares), CPMG Inc (8.48M shares), VR Adviser, LLC (6.87M shares), RA CAPITAL MANAGEMENT, L.P. (4.87M shares), BAKER BROS. ADVISORS LP (3.89M shares), WELLINGTON MANAGEMENT GROUP LLP (3.16M shares), ALLIANCEBERNSTEIN L.P. (2.83M shares), HHLR ADVISORS, LTD. (2.39M shares), and Samsara BioCapital, LLC (2.15M shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.